Autopsy report · NCT02901106

Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate

“Another surveillance protocol was initiated by the OFSEP (OFSEP cohort) which allows to follow all the patients, whatever their treatment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 5 months before it stopped.
• 11 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Sponsor type

University, hospital or other

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

Dimethyl fumarate

Participants

11

Sites

1

Countries

France

Trials that died the same way

• Optimized Caloric-proteic Nutrition in Septic and Septic Shock Patients
  “The protocol was modified substantially and will be resubmitted to Clinical Trial” (59% match in meaning)
• The Use of Laser in the Treatment of Atrophic Vulvovaginitis
  “This protocol was cancelled due to the COVID pandemic restrictions in our country. It was imposible to complete the recruitment of patients to achive the study objectives.” (57% match in meaning)
• Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
  “Initial version of the protocol not submitted and new version approved has a new sponsor and it has been added into Clinicaltrials by the new sponsor” (55% match in meaning)
• Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease
  “Per protocol, 3 sequential dose cohorts were planned. Study discontinued by Sponsor based upon serious adverse events in first 2 of 3 participants in Cohort 1.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.